Hospitalization for respiratory syncytial virus bronchiolitis and disease severity in twins

Miri Dotan1, Liat Ashkenazi-Hoffnung2, Zmira Samra3

  • 1Department of Pediatrics 1A, Schneider Children's Medical Center of Israel, Petah Tikva, Israel. miridotan@gmail.com

Insights

Infants born in multiple births, such as twins, do not face a higher risk of severe respiratory syncytial virus (RSV) infection compared to singletons. However, if one twin is hospitalized with RSV, the other has a significant chance of also requiring hospitalization.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Neonatology

Background:

  • Respiratory syncytial virus (RSV) is a leading cause of hospitalization in infants.
  • Infants from multiple births, often premature, may have increased susceptibility to severe RSV infections.

Purpose of the Study:

  • To evaluate the impact of multiple births on RSV infection severity in infants.
  • To identify risk factors for RSV infection acquisition in multiple birth infants.

Main Methods:

  • Retrospective collection of clinical data for infants hospitalized with RSV infection (2008-2010).
  • Analysis of demographic and clinical factors, including gestational age and prematurity.
  • Multivariable logistic regression to identify risk factors for severe outcomes like PICU admission.

Main Results:

  • Twins represented 7.6% of hospitalized infants with RSV bronchiolitis.
  • Twin infants were younger and had lower gestational ages than singletons.
  • Being a twin was not a significant risk factor for disease severity, but if one twin was hospitalized, the other had a 34% chance of also being hospitalized.

Conclusions:

  • Hospitalized twins with RSV bronchiolitis do not exhibit increased severity risk compared to singletons.
  • A twin sibling of an RSV-infected infant has a substantial risk of hospitalization, necessitating close monitoring.
  • Young age is a significant risk factor for the hospitalization of the second twin.
Abstract

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.8K
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
5.2K
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
1.8K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
768
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.2K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.4K